We studied B cell proliferation and differentiation in response to factors released by adherent monocytes in patients with systemic lupus erythematosus (SLE). Adherent cell supernatants (ACS) were added to peripheral blood mononuclear cells, and the effects on IgG synthesis, the number of Ig-secreting cells (ISC), and proliferation were determined. Exposure of SLE mononuclear cells to autologous ACS caused an increase (approximately twofold) in IgG production and ISC numbers. In contrast, exposure of normal mononuclear cells to autologous ACS did not significantly increase IgG production or ISC numbers. Addition of SLE ACS to cultures of normal mononuclear cells did not stimulate ISC production. There was no significant level of 'H-thymidine uptake by cultures of SLE or normal mononuclear cells in response to either SLE or normal ACS. In the presence of an excess number of autologous T cells, ACS stimulation of IgG synthesis was further enhanced. These findings indicate that adherent monocytes contribute to B cell hyperactivity in SLE by stimulating B cell differentiation. SLE mononuclear cells appear to be more responsive to ACS stimulation than are normal mononuclear cells. 'The response of normal resting B cells to foreign antigens is a complex sequence of events, which involves activation, proliferation, differentiation, and immunoglobulin secretion. The importance of an orderly and controlled progression through this sequence is emphasized by the extraordinary array of regulatory cells and lymphokines that are capable of acting on various stages of this pathway. Systemic lupus erythematosus (SLE) is an autoimmune disease that is associated with excessive B cell activity. Specifically, large amounts of immunoglobulin and numerous autoantibodies are secreted by SLE B cells, and the proportion of circulating B cells that spontaneously secrete Ig is markedly increased in SLE patients (1,2). Other abnormalities of B-lineage cells that have been reported in SLE patients include increased numbers of circulating immunoblasts (3), cells containing intracyloplasmic Ig (4), low numbers of circulating IgD-bearing cells (3, and increased surface Ig (sIg) negative, Ig-secreting cells (ISC) (6).Together these findings suggest that there are substantial abnormalities of the circulating B cell population in patients with SLE. Circulating immune complexes result from B cell hyperactivity and appear to cause certain of the pathologic manifestations of the disease (7). In an effort to understand the basis of SLE B cell hyperactivity, numerous studies have measured lymphokine levels and regulatory T cell and monocyte functions in vitro and in vivo. While many abnormalities have been found, it remains unclear at what stage in the maturation sequence these immunoregulatory abnormalities might contribute to SLE B cell hyperactivity.Recent studies at our laboratory have provided a unique opportunity to study SLE B cell proliferation